Theratechnologies Inc (TSE:TH) insider Christian Marsolais acquired 3,000 shares of the stock in a transaction dated Tuesday, July 18th. The stock was acquired at an average cost of C$7.12 per share, with a total value of C$21,360.00.
Shares of Theratechnologies Inc (TSE:TH) opened at 7.62 on Tuesday. Theratechnologies Inc has a 52 week low of $2.35 and a 52 week high of $8.72. The firm’s 50-day moving average price is $7.87 and its 200 day moving average price is $6.32. The firm’s market cap is $567.04 million.
ILLEGAL ACTIVITY NOTICE: “Insider Buying: Theratechnologies Inc (TSE:TH) Insider Acquires 3,000 Shares of Stock” was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://stocknewstimes.com/2017/08/15/insider-buying-theratechnologies-inc-tseth-insider-buys-3000-shares-of-stock-updated-updated-updated.html.
A number of brokerages have commented on TH. Scotiabank restated an “outperform” rating and set a C$9.50 price objective on shares of Theratechnologies in a research note on Wednesday, June 21st. National Bank Financial restated an “outperform” rating and set a C$7.15 price objective on shares of Theratechnologies in a research note on Thursday, May 4th. Finally, Canaccord Genuity reiterated a “speculative buy” rating and issued a C$7.50 price target on shares of Theratechnologies in a research note on Friday, May 5th.
About Theratechnologies
Theratechnologies Inc is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy.
Receive News & Ratings for Theratechnologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies Inc and related companies with MarketBeat.com's FREE daily email newsletter.
